Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury.

Autor:	H., Kazimoglu1 hkazimoglu@hotmail.com, E., Uysal2, M., Dokur3, A. O., Gurer4, K., Batcioglu5, B. A., Uyumlu5, E., Petekkaya6, M., Karadag7
Zdroj:	Bratislava Medical Journal / Bratislavské Lekárske Listy. 2020, Vol. 121 Issue 8, p547-553. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu